Formulated in glass fiber-filled and unfilled options, Nymax BIO materials include between 16 and 47 percent natural filler from renewable plant sources, including corn, straw, and wheat. Renewable, plant-based raw materials, have been shown to offer significantly lower product carbon footprint values than typical petroleum-based feedstock.

OnColor™ Infrared Sortable Black for Recyclable Packaging contain no carbon black pigment, permitting the automatic optical sorting sensors used in many waste management plants to detect black polymers and sort waste into the correct recycling streams. PHOTO CAPTION: OnColor™ Infrared Sortable Blacks Enable Detection and Recycling of Black Polymer Packaging in Waste Plants

We offer a wide variety of color and additive concentrates that are essential to improving the performance of crop-protection films, including both woven and nonwoven materials that protect plants from insects and sudden changes in temperature. By limiting transmission of infrared rays, IR absorbers can reduce daytime temperatures in the greenhouse, while light-diffusing agents scatter the sun’s rays for more uniform plant growth.

The new lab and plant will conduct cutting edge chemistry testing and evaluations to help customers tackle and overcome the challenge of plastics recycling and the goal of a circular economy. The demonstration plant mimics real world recycling in a research environment. 

SHANGHAI– September 25, 2024 – Today, Avient Corporation, a premier provider of specialty and sustainable materials solutions and services, announced it is expanding the manufacturing of its NEU™ Custom Capabilities and NEUSoft™ Thermoplastic Polyurethane (TPU) solution for catheter applications to its plant in Suzhou, China. The plant features climate-controlled environments, improved operational flow to maintain product integrity and consistency, and a specialized production room. 

Maxxam™ BIO bio-based polyolefins are formulated with 15-100% bio-based resin and/or natural filler from renewable plant sources. Avient is also pleased to announce its Nymax™ BIO bio-based polyamide formulations are now available in Europe, with formulations between 16% and 47% natural filler from renewable plant sources, including corn, straw, and wheat.

Manufacturing certificate overview for plants in Latin America (Portuguese  language version) Manufacturing certificate overview for plants in Latin America (Spanish language version)

Manufacturing certificate overview for plants in Latin America (Portuguese  language version) Manufacturing certificate overview for plants in Latin America (Spanish language version)

As part of the realignment, PolyOne will close manufacturing plants located in Diadema and Joinville, Brazil. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks; changes in polymer consumption growth rates where the Company conducts business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters, including any developments that would require any increase in the Company’s costs and/or reserves for such contingencies; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the speed and extent of an economic recovery, including the recovery of the housing markets; the financial condition of the Company’s customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; disruptions, uncertainty or volatility in the credit markets that may limit the Company’s access to capital; other factors affecting the Company’s business beyond the Company’s control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation; the Company’s ability to realize anticipated savings and operational benefits from the realignment of assets, including the planned closure of certain manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen disruptions of service or quality caused by such closings and/or production shifts; the timing of the recognition of the charges that will be incurred; separation and severance amounts and plant exit costs that differ from original estimates; amounts for non-cash charges related to asset write-offs, asset impairments, and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; the Company’s ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired companies into the Company’s operations, retain the management teams of acquired companies, and retain relationships with customers of acquired companies, including, without limitation, Spartech Corporation; and other factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2013 under Item 1A, “Risk Factors.”

The plant, which is already fully operational, becomes the fourth global source for MEVOPUR™ polymer solutions, which are produced under carefully controlled conditions to support more reliable compliance with regulations governing medical devices and pharmaceutical packaging. ISO 13485 certification is the culmination of two years’ work to create a completely segregated, dedicated healthcare operation similar to other MEVOPUR plants.